Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What is Adjuvant! Online?

April 26, 2017adjuvant online

0

Posted

What is Adjuvant! Online?

1 Answer

0

Posted

At the heart of this trial is the hypothesis that genomic risk assessment will outperform clinical-pathological risk assessment. Therefore, much attention has been devoted to defining the best possible clinical-pathological risk assessment as it is the control group. The TRANSBIG Steering Committee agreed to use a modified version of Adjuvant! Online for the clinical-pathological risk assessment. Adjuvant! Online is a web-based decision tool developed by Dr. Peter Ravdin of the University of Texas in San Antonio. This model calculates the risk of relapse and death for breast cancer patients at ten years. This tool is user-friendly, widely available and popular with physicians around the world. Dr. Ravdin has worked actively with TRANSBIG and is a member of the TRANSBIG Steering committee.